Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Working Capital/Sales

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Working Capital/Sales History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 0.811.511.791.091.62

What is the latest Working Capital/Sales ratio of GENPHARMASEC ?

The latest Working Capital/Sales ratio of GENPHARMASEC is 0.81 based on Mar2024 Standalone results.
Year Working Capital/Sales
Mar20240.81
Mar20231.51
Mar20221.79
Mar20211.09
Mar20201.62

How is Working Capital/Sales of GENPHARMASEC Trending?

Years Working Capital/Sales % Change
Mar2024 0.81
-46.36
Mar2023 1.51
-15.64
Mar2022 1.79
64.22
Mar2021 1.09
-32.72
Mar2020 1.62 -

Other Financial Ratios of GENPHARMASEC


Compare Working Capital/Sales ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹124.0 Cr -2.2% -26.1% -47.1% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,167.4 Cr -8.1% -18.1% 78.6% Stock Analytics
KIRI INDUSTRIES ₹2,994.0 Cr -12.3% -6.5% 53.5% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,247.3 Cr -2.2% -9.5% 11% Stock Analytics
BODAL CHEMICALS ₹771.7 Cr -2.9% -5.3% -15.6% Stock Analytics
BHAGERIA INDUSTRIES ₹752.2 Cr -10.2% -3.2% 7% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-2.2%

-26.1%

-47.1%

SENSEX

-2.5%

-1.4%

6.1%


You may also like the below Video Courses